In this issue:
Shorter treatment course for nonsevere TB
Nirsevimab for preventing RSV in infants
Gefapixant for refractory, unexplained chronic cough
Treatment patterns and key outcomes in paediatric acute severe asthma
TSANZ position statement on acute oxygen use in adults
Budesonide-formoterol for maintenance and reliever therapy in poorly controlled asthma
Elexacaftor + tezacaftor-ivacaftor in cystic fibrosis homozygous for F508del-CFTR
Long-term air pollution exposure and COVID-19 mortality
Long-term tocilizumab in early systemic sclerosis-ILD
Factors impairing exercise capacity after severe COVID-19 pulmonary infection
Please login below to download this issue (PDF)